fda compounding semaglutide crackdown 2025 news The is drawing a harder line on compounded weight loss drug marketing. In the May–June 2026 issue of Dispense Times, this article breaks down key violations cited in recent FDA enforcement Compounded Semaglutide Reviews 2025: Consumer
Description
Where are your medical providers located
If you have been inadvertently using expired semaglutide, monitor your blood glucose levels more frequently (for diabetes patients) and watch for any signs of reduced effectiveness or unusual symptoms
The FDA has warned about potential risks, including serious side effects, from unapproved compounded versions, especially when they use different forms of the active ingredient (like "semaglutide sodium" or "tirzepatide acetate") than the approved drugs
Do they work differently
The day that, week after week, month after month, offers the most reliability
